Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study
This study examined the association between peritoneal cytology and survival in early-stage cervical cancer. This is a nationwide multicenter retrospective study, examining consecutive women with clinical stage IB1-IIB cervical cancer who underwent radical hysterectomy with available peritoneal cyto...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/8/11/1822 |
id |
doaj-b1d2b24af07d49028e2cccfef02916da |
---|---|
record_format |
Article |
spelling |
doaj-b1d2b24af07d49028e2cccfef02916da2020-11-25T02:32:55ZengMDPI AGJournal of Clinical Medicine2077-03832019-11-01811182210.3390/jcm8111822jcm8111822Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group StudyKoji Matsuo0Muneaki Shimada1Shinya Matsuzaki2Hiroko Machida3Yoshikazu Nagase4Toshiaki Saito5Shoji Kamiura6Takashi Iwata7Toru Sugiyama8Mikio Mikami9Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA 90033, USADepartment of Obstetrics and Gynecology, Tottori University, Tottori 683-8504, JapanDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA 90033, USADepartment of Obstetrics and Gynecology, Tokai University, Kanagawa 259-1193, JapanDepartment of Obstetrics and Gynecology, Osaka University, Osaka 565-0871, JapanGynecology Service, National Hospital Organization Kyushu Cancer Center, Fukuoka 811-1395, JapanDepartment of Gynecologic Oncology, Osaka International Cancer Institute, Osaka 541-8567, JapanDepartment of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo 160-8582, JapanDepartment of Obstetrics and Gynecology, Iwate Medical University, Iwate 020-8505, JapanDepartment of Obstetrics and Gynecology, Tokai University, Kanagawa 259-1193, JapanThis study examined the association between peritoneal cytology and survival in early-stage cervical cancer. This is a nationwide multicenter retrospective study, examining consecutive women with clinical stage IB1-IIB cervical cancer who underwent radical hysterectomy with available peritoneal cytology results from 2004−2008. Propensity score inverse probability of treatment weighting was used to assess the impact of malignant peritoneal cytology on survival. Among 1409 analyzed cases, 88 (6.2%) had malignant peritoneal cytology. On weighted models, malignant peritoneal cytology was associated with decreased disease-free survival (hazard ratio (HR) 1.78, 95% confidence interval (CI) 1.36−2.32) and overall survival (OS, HR 1.93, 95% CI 1.44−2.59). On sensitivity analyses, malignant peritoneal cytology was associated with decreased OS in adenocarcinoma/adenosquamous carcinoma, high-risk early-stage disease and those who received concurrent chemo-radiotherapy. However, among women who received postoperative systemic chemotherapy, malignant peritoneal cytology was not associated with OS (HR 1.21, 95% CI 0.72−2.04). A systematic review, including our results, showed that malignant peritoneal cytology was associated with decreased OS (HR 4.03, 95% CI 1.81−8.99) and increased recurrence in squamous carcinoma (odds ratio 1.89, 95% CI 1.05−3.39) and adenocarcinoma (odds ratio 4.30, 95% CI 2.30−8.02). In conclusion, the presence of malignant cells in peritoneal cytology is associated with decreased survival in early-stage cervical cancer. The possible benefit of systemic chemotherapy in this subgroup merits further investigation.https://www.mdpi.com/2077-0383/8/11/1822cervical cancerradical hysterectomyperitoneal cytology: malignant cytologyadjuvant therapychemotherapysurvival |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Koji Matsuo Muneaki Shimada Shinya Matsuzaki Hiroko Machida Yoshikazu Nagase Toshiaki Saito Shoji Kamiura Takashi Iwata Toru Sugiyama Mikio Mikami |
spellingShingle |
Koji Matsuo Muneaki Shimada Shinya Matsuzaki Hiroko Machida Yoshikazu Nagase Toshiaki Saito Shoji Kamiura Takashi Iwata Toru Sugiyama Mikio Mikami Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study Journal of Clinical Medicine cervical cancer radical hysterectomy peritoneal cytology: malignant cytology adjuvant therapy chemotherapy survival |
author_facet |
Koji Matsuo Muneaki Shimada Shinya Matsuzaki Hiroko Machida Yoshikazu Nagase Toshiaki Saito Shoji Kamiura Takashi Iwata Toru Sugiyama Mikio Mikami |
author_sort |
Koji Matsuo |
title |
Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study |
title_short |
Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study |
title_full |
Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study |
title_fullStr |
Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study |
title_full_unstemmed |
Significance of Malignant Peritoneal Cytology on the Survival of Women with Early-Stage Cervical Cancer: A Japanese Gynecologic Oncology Group Study |
title_sort |
significance of malignant peritoneal cytology on the survival of women with early-stage cervical cancer: a japanese gynecologic oncology group study |
publisher |
MDPI AG |
series |
Journal of Clinical Medicine |
issn |
2077-0383 |
publishDate |
2019-11-01 |
description |
This study examined the association between peritoneal cytology and survival in early-stage cervical cancer. This is a nationwide multicenter retrospective study, examining consecutive women with clinical stage IB1-IIB cervical cancer who underwent radical hysterectomy with available peritoneal cytology results from 2004−2008. Propensity score inverse probability of treatment weighting was used to assess the impact of malignant peritoneal cytology on survival. Among 1409 analyzed cases, 88 (6.2%) had malignant peritoneal cytology. On weighted models, malignant peritoneal cytology was associated with decreased disease-free survival (hazard ratio (HR) 1.78, 95% confidence interval (CI) 1.36−2.32) and overall survival (OS, HR 1.93, 95% CI 1.44−2.59). On sensitivity analyses, malignant peritoneal cytology was associated with decreased OS in adenocarcinoma/adenosquamous carcinoma, high-risk early-stage disease and those who received concurrent chemo-radiotherapy. However, among women who received postoperative systemic chemotherapy, malignant peritoneal cytology was not associated with OS (HR 1.21, 95% CI 0.72−2.04). A systematic review, including our results, showed that malignant peritoneal cytology was associated with decreased OS (HR 4.03, 95% CI 1.81−8.99) and increased recurrence in squamous carcinoma (odds ratio 1.89, 95% CI 1.05−3.39) and adenocarcinoma (odds ratio 4.30, 95% CI 2.30−8.02). In conclusion, the presence of malignant cells in peritoneal cytology is associated with decreased survival in early-stage cervical cancer. The possible benefit of systemic chemotherapy in this subgroup merits further investigation. |
topic |
cervical cancer radical hysterectomy peritoneal cytology: malignant cytology adjuvant therapy chemotherapy survival |
url |
https://www.mdpi.com/2077-0383/8/11/1822 |
work_keys_str_mv |
AT kojimatsuo significanceofmalignantperitonealcytologyonthesurvivalofwomenwithearlystagecervicalcancerajapanesegynecologiconcologygroupstudy AT muneakishimada significanceofmalignantperitonealcytologyonthesurvivalofwomenwithearlystagecervicalcancerajapanesegynecologiconcologygroupstudy AT shinyamatsuzaki significanceofmalignantperitonealcytologyonthesurvivalofwomenwithearlystagecervicalcancerajapanesegynecologiconcologygroupstudy AT hirokomachida significanceofmalignantperitonealcytologyonthesurvivalofwomenwithearlystagecervicalcancerajapanesegynecologiconcologygroupstudy AT yoshikazunagase significanceofmalignantperitonealcytologyonthesurvivalofwomenwithearlystagecervicalcancerajapanesegynecologiconcologygroupstudy AT toshiakisaito significanceofmalignantperitonealcytologyonthesurvivalofwomenwithearlystagecervicalcancerajapanesegynecologiconcologygroupstudy AT shojikamiura significanceofmalignantperitonealcytologyonthesurvivalofwomenwithearlystagecervicalcancerajapanesegynecologiconcologygroupstudy AT takashiiwata significanceofmalignantperitonealcytologyonthesurvivalofwomenwithearlystagecervicalcancerajapanesegynecologiconcologygroupstudy AT torusugiyama significanceofmalignantperitonealcytologyonthesurvivalofwomenwithearlystagecervicalcancerajapanesegynecologiconcologygroupstudy AT mikiomikami significanceofmalignantperitonealcytologyonthesurvivalofwomenwithearlystagecervicalcancerajapanesegynecologiconcologygroupstudy |
_version_ |
1724816854284763136 |